original ) (raw )Modulation of the endocannabinoid system: Neuroprotection or neurotoxicity
Antonio Gaztelumendi
Experimental Neurology, 2010
View PDFchevron_right
Methamphetamine neurotoxicity increases brain expression and alters behavioral functions of CB1 cannabinoid receptors
Maria Collu
Journal of Psychiatric Research, 2010
View PDFchevron_right
Endocannabinoids and striatal function
David Belin
Behavioural Pharmacology, 2015
View PDFchevron_right
Attenuation Effect of Cannabinoid Type 1 Receptor Activation on Methamphetamine-Induced Neurodegeneration and Locomotion Impairments among Male Rats
Gholamreza Sepehri
Addiction & Health, 2017
View PDFchevron_right
Altered cannabinoid CB1 receptor mRNA expression in mesencephalon from mice exposed to repeated methamphetamine and methanandamide treatments
Alexandra Sulcova
Neuro endocrinology letters, 2011
View PDFchevron_right
Enhancement of endocannabinoid signalling protects against cocaine-induced neurotoxicity
Daniele Aguiar
Toxicology and Applied Pharmacology, 2015
View PDFchevron_right
The dual neuroprotective-neurotoxic profile of cannabinoid drugs
Yosef Sarne
British Journal of Pharmacology, 2011
View PDFchevron_right
Differential effects of acute cannabinoid drug treatment, mediated by CB 1 receptors, on the in vivo activity of tyrosine and tryptophan hydroxylase in the rat brain
David Moranta
Naunyn Schmied Arch Pharmacol, 2004
View PDFchevron_right
Research Paper Cannabidiol Modulating the Expression of Neurotrophin Signaling Pathways in Chronic Exposure to Methamphetamine in Rats During Abstinence Period
Mehdi Mehdizadeh , Basic and Clinical Neuroscience Journal
Basic and Clinical Neuroscience (BCN), 2022
View PDFchevron_right
Methamphetamine Blocks Adenosine A2A Receptor Activation via Sigma 1 and Cannabinoid CB1 Receptors
Gemma Navarro
International Journal of Molecular Sciences, 2021
View PDFchevron_right
Blockade of cannabinoid CB1 receptor function protects against in vivo disseminating brain damage following NMDA-induced excitotoxicity: Neuroprotection by CB1 receptor antagonism
Iñigo Azcoitia
Journal of Neurochemistry, 2002
View PDFchevron_right
Cannabinoids in the Brain: New Vistas on an Old Dilemma
Jean-François Bouchard
Neural Plasticity, 2016
View PDFchevron_right
Role of Cannabinoid Type 1 Receptors in Locomotor Activity and Striatal Signaling in Response to Psychostimulants
Jean-antoine Girault
Journal of Neuroscience, 2007
View PDFchevron_right
Molecular Mechanisms of Cannabinoid Protection from Neuronal Excitotoxicity
Seok Won
Molecular Pharmacology, 2005
View PDFchevron_right
Targeting the endocannabinoid system: a predictive, preventive, and personalized medicine-directed approach to the management of brain pathologies
Pankaj Gaur
EPMA Journal, 2020
View PDFchevron_right
Delta9 -THC and WIN55,212-2 affect brain tissue levels of excitatory amino acids in a phenotype-, compound-, dose-, and region-specific manner
George Nomikos
Beavioural Brain Research, 2011
View PDFchevron_right
Δ9-THC and WIN55,212-2 affect brain tissue levels of excitatory amino acids in a phenotype-, compound-, dose-, and region-specific manner
Andreas Galanopoulos
Behavioural Brain Research, 2011
View PDFchevron_right
Chronic Effects of Cannabinoid Drugs on Monoaminergic Systems and the Role of Endocannabinoids and Cannabinoid Receptors in Human Brain Disorders
Susana Aguilar Esteban
Endocannabinoid Regulation of Monoamines in Psychiatric and Neurological Disorders, 2013
View PDFchevron_right
Protective effect of the radical scavenger edaravone against methamphetamine-induced dopaminergic neurotoxicity in mouse striatum
Yukio Ago , Akemichi Baba
European Journal of Pharmacology, 2006
View PDFchevron_right
Mechanisms of Control of Neuron Survival by the Endocannabinoid System
Tania Aguado
Current Pharmaceutical Design, 2008
View PDFchevron_right
Endocannabinoids and neurodegenerative diseases
Vincenzo Micale
Pharmacological Research, 2007
View PDFchevron_right
Neurobehavioral effects of Δ9-THC and cannabinoid (CB1) receptor gene expression in mice
Emmanuel Onaivi
Behavioural Brain Research, 1995
View PDFchevron_right
Altered dopamine D1 and D2 receptor mRNA expression in mesencephalon from mice exposed to repeated treatments with methamphetamine and cannabinoid CB1 agonist methanandamide
Alexandra Sulcova
Neuro endocrinology letters, 2012
View PDFchevron_right
Methamphetamine Preconditioning Alters Midbrain Transcriptional Responses to Methamphetamine-Induced Injury in the Rat Striatum
Genevieve Beauvais
PLOS One, 2009
View PDFchevron_right
Modulation of the endocannabinoid system: vulnerability factor and new treatment target for stimulant addiction
Stéphane Potvin
Frontiers in psychiatry, 2013
View PDFchevron_right
Δ9-Tetrahydrocannabinol protects hippocampal neurons from excitotoxicity
Jon Waataja
2007
View PDFchevron_right
The JNK inhibitor, SP600125, potentiates the glial response and cell death induced by methamphetamine in the mouse striatum
Maria Colado , Rosario Moratalla
The International Journal of Neuropsychopharmacology, 2013
View PDFchevron_right
Endocannabinoids affect neurological and cognitive function in thioacetamide-induced hepatic encephalopathy in mice
Iddo Magen
Neurobiology of Disease, 2006
View PDFchevron_right
Role of CB< sub> 2 receptors in neuroprotective effects of cannabinoids
Ruth Pazos
Molecular and cellular …, 2008
View PDFchevron_right
Role of CB 2 receptors in neuroprotective effects of cannabinoids
Moises Fernandez Garcia
Molecular and Cellular Endocrinology, 2008
View PDFchevron_right
In vivo neurochemical effects induced by changes in endocannabinoid neurotransmission
Aldemar Degroot
Current Opinion in Pharmacology, 2007
View PDFchevron_right
The endocannabinoid system: an overview
Monica Bari
Frontiers in Behavioral Neuroscience, 2012
View PDFchevron_right
Endocannabinoids in Liver Disease and Hepatic Encephalopathy
Iddo Magen
Current Pharmaceutical Design, 2008
View PDFchevron_right